PMS38 - COST EFFECTIVENESS ANALYSIS OF SECUKINUMAB VERSUS USTEKINUMAB FOR THE TREATMENT OF PSORIATIC ARTHRITIS IN THE UNITED STATES
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1752
https://www.valueinhealthjournal.com/article/S1098-3015(18)35054-X/fulltext
Title :
PMS38 - COST EFFECTIVENESS ANALYSIS OF SECUKINUMAB VERSUS USTEKINUMAB FOR THE TREATMENT OF PSORIATIC ARTHRITIS IN THE UNITED STATES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35054-X&doi=10.1016/j.jval.2018.09.1752
First page :
Section Title :
Open access? :
No
Section Order :
1118